Stock market today: S&P 500 hits fresh record close on stronger economic growth
Wellgistics Health , Inc. (NASDAQ:WGRX) announced Monday that its board of directors approved the dismissal of Suri & Co., Chartered Accountants as the company’s independent registered public accounting firm, and appointed UHY LLP as its new auditor effective the same day.
According to the company’s statement in a Securities and Exchange Commission filing, Suri & Co.’s audit reports on Wellgistics Health’s consolidated financial statements for the years ended December 31, 2024 and 2023 included a note regarding the company’s ability to continue as a going concern. Other than this note, Suri & Co.’s reports did not contain any adverse opinions, disclaimers of opinion, or qualifications as to uncertainty, audit scope, or accounting principles.
The filing further stated that during the fiscal years ended December 31, 2024 and 2023, as well as the interim period through July 7, 2025, there were no disagreements between Wellgistics Health and Suri & Co. on any matters of accounting principles, practices, financial statement disclosure, or auditing scope or procedures that would have required disclosure. The company also reported that there were no reportable events as defined by SEC regulations during this period.
Wellgistics Health has provided Suri & Co. with a copy of the disclosures in the current report and requested that Suri & Co. furnish a letter addressed to the SEC stating whether it agrees with the statements made. A copy of this letter, dated Tuesday, was filed as an exhibit to the report.
The company also confirmed that, prior to the appointment, neither Wellgistics Health nor anyone acting on its behalf consulted with UHY LLP regarding the application of accounting principles to a specific transaction or the type of audit opinion that might be rendered on the company’s financial statements, nor were there any matters that were the subject of a disagreement or reportable event.
This information is based on a statement made in a press release filed with the Securities and Exchange Commission.
In other recent news, Wellgistics Health, Inc. has announced several strategic initiatives and developments. The company has adopted XRP, a blockchain-based digital asset, for its treasury reserves and real-time payments, supported by a $50 million Equity Line of Credit. This adoption aims to enhance transaction speed, reduce costs, and increase transparency within its healthcare network. In another significant move, Wellgistics Health has converted $1.5 million of debt into 333,333 shares of common stock, with CEO Brian Norton committing to hold these shares under a 12-month lock-up agreement. Additionally, Wellgistics Health has acquired Peek Healthcare Technologies, Inc., which operates the Peek Meds Marketplace, to enhance its digital healthcare ecosystem and offer real-time prescription pricing transparency. This acquisition is expected to reduce prescription costs and expand commercialization services for pharmaceutical manufacturers. The company also highlights its focus on creating a micro health ecosystem through integrated solutions for pharmacies and healthcare providers. These recent developments underscore Wellgistics Health’s commitment to innovation and efficiency in the healthcare sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.